Diagnostic and Prognostic Value of p16INK4a Expression in Low Grade Squamous Intraepithelial Lesions of the Cervix.

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Unknown status
CT.gov ID
NCT00343213
Collaborator
(none)
300
3
100

Study Details

Study Description

Brief Summary

P16INK4a has recently been described as a surrogate marker for HR-HPV associated squamous and glandular intraepithelial lesions of the cervix. The immunohistochemical staining pattern of p16INK4a in high grade intraepithelial neoplasia of the cervix (CIN 2 and 3) is diffuse, whereas in CIN 1 different staining patterns (diffuse, sporadic, focal or negative) can be seen. The aim of our study is to find out whether the p16INK4a staining pattern of CIN 1 is able to predict the outcome of the lesion. The retrospective part of the study includes cervical biopsies of 200 patients with CIN 1 and clinical follow-up for at least 5 years. p16INK4a staining and HPV detection by IHC will be correlated to clinical outcome.The prospective part of the study includes 300 patients with CIN 1 and LSIL on cytology. HPV detection by HCII and p16INK4a immunohistochemistry on liquid based cytology samples as well as p16INK4a staining and HPV detection by ISH on colposcopy guided biopsies will be correlated to clinical follow-up and colposcopy findings. Slides are analysed by 2 pathologists without knowledge of clinical data.

Condition or Disease Intervention/Treatment Phase
  • Procedure: colposcopy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
300 participants
Allocation:
Non-Randomized
Intervention Model:
Factorial Assignment
Masking:
Double
Primary Purpose:
Prevention
Official Title:
Diagnostic and Prognostic Value of p16INK4a Expression in Low Grade Squamous Intraepithelial Lesions of the Cervix. Immunohistochemical Study on Biopsies (Retrospective and Prospective Analysis) and on Liquid Based (SurePath) Cervical Cytology (Prospective Analysis). Correlation With HPV Typing and Clinical Outcome.
Study Start Date :
Jun 1, 2006

Outcome Measures

Primary Outcome Measures

  1. p16INK4a staining pattern and HPV status of the initial biopsy []

Secondary Outcome Measures

  1. p16INK4a staining pattern and histologic diagnosis of follow-up biopsies correlated with colposcopic findings. []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No

Responsible women > 18 years with histologically proven CIN 1

Contacts and Locations

Locations

Site City State Country Postal Code
1 Service de Gynécologie-Obstétrique - Centre Hospitalier Général Haguenau France
2 Service de gynécologie-obtétrique - Centre Hospitalier Général Saverne France
3 Département de Gynécologie-Obstétrique - Hôpital de Hautepierre Strasbourg France 67098

Sponsors and Collaborators

  • University Hospital, Strasbourg, France

Investigators

  • Study Director: Jean-Jacques Baldauf, MD, Département de Gynécologie-Obstétrique - Hôpital de Hautepierre - Strasbourg - France

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00343213
Other Study ID Numbers:
  • 3454
First Posted:
Jun 22, 2006
Last Update Posted:
Aug 30, 2011
Last Verified:
Aug 1, 2011

Study Results

No Results Posted as of Aug 30, 2011